Thrombotic phenomena in the presence of a circulating anticoagulant
Quintero, A.L.; Lugo-Somolinos, A.; Sánchez, J.L.
Boletin de la Asociacion Medica de Puerto Rico 82(10): 444-447
1990
ISSN/ISBN: 0004-4849 PMID: 2127888 Document Number: 358766
Document emailed within 1 workday
Related Documents
Font, J.; Cervera, R.; Casals, F.J.; Bové, A.; Guerrero, A.; López-Soto, A.; Ingelmo, M.; Urbano-Márquez, A. 1988: Relation of antiphospholipid antibodies to thrombotic phenomena and clinical activity of systemic lupus erythematosus Medicina Clinica 90(12): 490-493Mahanonda, N. 1998: Anti-thrombotic and anticoagulant treatment in interventional cardiology Journal of the Medical Association of Thailand 81(1): 42-46
Bachaud, M.; Massip, P.; Boneu, B.; Armengaud, M. 1983: Circulating anticoagulant in Q fever Presse Medicale 12(15): 963
Besancenot, J.F.; Cannard, J.F.; Janin-Manificat, L.; Auplat, P.H.; Cortet, P. 1983: Q fever and circulating anticoagulant Presse Medicale 12(35): 2188
Muzellec, Y.; Carli, P.; Talard, P.; Pignon, D.; Chagnon, A. 1989: Circulating anticoagulant in lepromatous leprosy Presse Medicale 18(18): 938
Shoenfeld, Y.; Shaulian, E.; Shaklai, M.; Kruglack, J.; Feuerman, E.; Pinkhas, J. 1980: Circulating anticoagulant and serological tests for syphilis Acta Dermato-Venereologica 60(4): 365-367
Shaulian, E.; Shoenfeld, Y.; Berliner, S.; Shaklai, M.; Pinkhas, J. 1981: Surgery in patients with circulating lupus anticoagulant International Surgery 66(2): 157-159
Heudier, P.; Taillan, B.; Perrin, C.; Bayle, J.; Fuzibet, J.G.; Dujardin, P. 1993: Circulating lupus anticoagulant in typhoid fever Presse Medicale 22(15): 738
Ford, S.E.; Lillicrap, D.; Brunet, D.; Ford, P. 1989: Thrombotic endocarditis and lupus anticoagulant. a pathogenetic possibility for idiopathic 'rheumatic type' valvular heart disease Archives of Pathology and Laboratory Medicine 113(4): 350-353
Sandler, B.; Bentegeat, J.; Darmendrail, J.; Chatelan, M.; Authier, F.; Ainciburu, P.M.; Bertin, J.B.; Cheylac, J.Y.; Sautarel, M. 1976: Disseminated lupus erythematosus with circulating anticoagulant (proceedings) Pediatrie 31(6): 624-625
Devars du Mayne, J.F.; Molinié, V.; Pradalier, A. 1997: Hepatic granulomatosis associated with a circulating anticoagulant, disclosing Q fever Presse Medicale 26(14): 666
Good, A.E.; Cassidy, J.T.; Mutchnick, M.G.; Reed, R.E.; Lederman, H.M. 1977: Ankylosing spondylitis with selective IgA deficiency and a circulating anticoagulant Journal of Rheumatology 4(3): 297-302
Arakawa, M.; Yoshida, K.; Sasaki, Y.; Satou, H.; Saitou, T. 1995: A case of hemolytic uremic syndrome associated with circulating anticoagulant Nihon Jinzo Gakkai Shi 37(9): 523-528
Shoenfeld, Y.; Pick, A.I.; Gura, V.; Frohlichman, R.; Pinkhas, J. 1978: Systemic lupus erythematosus associated with mixed cryoglobulinaemia and circulating anticoagulant South African Medical Journal 54(25): 1056-1058
Taillan, B.; Ferrari, E.; Fuzibet, J.G.; Vinti, H.; Gratecos, N.; Dujardin, P. 1991: Acquired anti-factor V circulating anticoagulant and immunologic diseases Revuedu Rhumatisme et des Maladies Osteo-Articulaires 58(3): 232
Nick, J.; Combrisson, A.; Reignier, A.; Verdy, E.; Gally, A.M.; Bakouche, P.; Dudognon, P.; Dray, C. 1978: Iatrogenic procaine amide-induced lupus with circulating anticoagulant Annales de Medecine Interne 129(4): 259-263
Reymond, O.; Stalder, J.B.; Stalder, M.; The, H.N.; Bossart, H. 1987: Lupus erythematosus, circulating anticoagulant and obstetric complications. Apropos of 2 cases Journal de Gynecologie Obstetrique et Biologie de la Reproduction 16(2): 207-211
Pattison, N.S.; McKay, E.J.; Liggins, G.C.; Lubbe, W.F. 1987: Anticardiolipin antibodies: their presence as a marker for lupus anticoagulant in pregnancy New Zealand Medical Journal 100(817): 61-64
Chagnon, A.; Peres, C.; Camilleri, G.; Abgrall, J.; Verdier, M. 1982: Lupic syndrome induced by quinidine with thrombophlebitis alternans and circulating anti-factor IX anticoagulant La Nouvelle Presse Medicale 11(26): 2020-2021
Rauch, J.; Tannenbaum, M.; Neville, C.; Fortin, P.R. 1998: Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin Thrombosis and Haemostasis 80(6): 936-941